Price
Financials
Consolidated, Rs crore| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|
| Sales | 539 | 981 | 1,162 | 1,425 | 1,771 | 2,265 | 569 |
| Expenses | 437 | 805 | 897 | 1,077 | 1,321 | 2,016 | 626 |
| Operating Profit | 102 | 176 | 264 | 348 | 450 | 248 | -57 |
| OPM % | 19% | 18% | 23% | 24% | 25% | 11% | -10% |
| Other Income | 4 | 0 | 7 | 6 | 22 | 13 | 2 |
| Interest | 38 | 82 | 143 | 167 | 242 | 307 | 332 |
| Depreciation | 18 | 33 | 52 | 66 | 84 | 96 | 104 |
| Profit before tax | 50 | 61 | 76 | 122 | 146 | -141 | -491 |
| Tax % | 28% | 30% | 27% | 29% | 27% | 10% | -13% |
| Net Profit | 35 | 43 | 56 | 87 | 106 | -154 | -428 |
| EPS in Rs | |||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -10% | -26% | -75% | ||
| Compounded Profit Growth | % | % | % | -161% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | -9% | -19% | -39% |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 25 | 25 | 28 | 28 |
| Reserves | 325 | 362 | 443 | 650 | 750 | 751 | 1,307 |
| Borrowings | 420 | 954 | 1,248 | 1,382 | 1,615 | 2,386 | 3,145 |
| Other Liabilities | 103 | 257 | 322 | 441 | 678 | 847 | 472 |
| Total Liabilities | 869 | 1,594 | 2,035 | 2,498 | 3,067 | 4,012 | 4,952 |
| Fixed Assets | 301 | 529 | 645 | 768 | 848 | 921 | 1,795 |
| CWIP | 32 | 135 | 97 | 30 | 63 | 34 | 31 |
| Investments | 19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 518 | 930 | 1,293 | 1,699 | 2,156 | 3,057 | 3,125 |
| Total Assets | 869 | 1,594 | 2,035 | 2,498 | 3,067 | 4,012 | 4,952 |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -183 | -17 | 187 | 239 | -447 | -511 | |
| Cash from Investing Activity | -339 | -132 | -262 | -187 | -150 | -2 | |
| Cash from Financing Activity | 466 | 169 | 77 | -25 | 630 | 426 | |
| Net Cash Flow | -55 | 20 | 1 | 27 | 33 | -86 | |
| Free Cash Flow | -540 | -142 | -68 | 72 | -609 | -514 | |
| CFO/OP | -100% | -2% | 59% | 61% | -177% | 892% |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 111 | 132 | 168 | 153 | 152 | 189 | 911 |
| Inventory Days | 180 | 204 | 217 | 213 | 211 | 215 | 672 |
| Days Payable | 80 | 53 | 111 | 144 | 179 | 148 | 279 |
| Cash Conversion Cycle | 212 | 283 | 275 | 222 | 184 | 256 | 1,304 |
| Working Capital Days | 229 | 257 | 307 | 282 | 239 | 299 | 1,485 |
| ROCE % | 14% | 14% | 15% | 17% | 6% | -4% |
Fundamentals
Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE-4.12 %
ROE-39.3 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)-75%
Compounded Profit Growth (TTM)-161%
Consolidated figures.
Profitability
Operating margin (excl. other income)24.44%
Operating margin (incl. other income)24.89%
EBITDA margin24.89%
Pre-tax margin8.55%
Net profit margin5.85%
ROE14.65%
ROCE15.32%
ROA3.68%
ROE, 3-year average12.71%
ROCE, 3-year average14.44%
ROA, 3-year average3.29%
ROIC (approx.)10.33%
Tax rate28.72%
Other income / net worth0.96%
Growth
Sales growth (latest year)22.67%
Profit growth (latest year)58.06%
Sales CAGR, 3 years38.25%
Profit CAGR, 3 years35.02%
Per share
EPS (TTM)Rs 33.65
EPS (latest year)Rs 33.65
EPS, 3-year averageRs 25.83
Book value per shareRs 272.18
Sales per shareRs 575.05
Cash flow per shareRs 75.50
Free cash flow per shareRs -207.39
Efficiency
Asset turnover0.57x
Fixed asset turnover1.86x
Inventory turnover1.91x
Inventory days191 days
Debtor days153 days
Debtors turnover2.38x
Creditor days279 days
Cash conversion cycle1304 days
Working capital days1485 days
Leverage
Total debtRs 1,382 Cr
Cash and bankRs 65 Cr
Net debtRs 1,317 Cr
Debt to equity2.05x
Net debt / EBITDA3.71x
Interest coverage1.73x
Owners' fund to total sources27.01%
Debt to assets55.34%
Cash flow
Cash from Operating Activity (latest year)Rs 187 Cr
Cash from Investing Activity (latest year)Rs -262 Cr
Cash from Financing Activity (latest year)Rs 77 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -514 Cr
FCFE (approx.: FCF + change in debt)Rs -380 Cr
Sales to cash flow7.62x
Statement figures
Net sales (TTM)Rs 1,425 Cr
Net sales (latest year)Rs 1,425 Cr
Operating profit excl. other income (latest year)Rs 348 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs 355 Cr
PBDT (TTM)Rs 188 Cr
Profit before tax (TTM)Rs 122 Cr
Tax (latest year)Rs 35 Cr
Net profit (TTM)Rs 83 Cr
Net profit (latest year)Rs 83 Cr
Depreciation (TTM)Rs 66 Cr
Interest (TTM)Rs 167 Cr
Cost of goods sold (latest year)Rs 955 Cr
Total expenditure (latest year)Rs 1,077 Cr
Total income (latest year)Rs 1,432 Cr
Share capitalRs 25 Cr
ReservesRs 650 Cr
Shareholders' fundsRs 675 Cr
Total assetsRs 2,498 Cr
Net blockRs 768 Cr
Capital work in progressRs 30 Cr
InvestmentsRs 0 Cr
ReceivablesRs 598 Cr
InventoryRs 499 Cr
Other liabilitiesRs 441 Cr
Shares outstanding (crore)2.48
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 6 of 8| explain | Weak cash conversion Cash from operations was -7% of net profit over the last 3 years |
| look | Share dilution Share count up 17% in a year, 17% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Arch Pharmalabs Ltd?
Arch Pharmalabs Ltd (524729) has a market capitalisation of Rs Cr. at the close.